Avanos Medical (AVNS) Operating Leases (2019 - 2026)

Avanos Medical's Operating Leases history runs 8 years deep, the most recent figure standing at $29.8 million for Q1 2026.

• In Q1 2026, Operating Leases rose 29.0% year-over-year to $29.8 million; the TTM figure through Mar 2026 stood at $29.8 million (up 29.0% YoY), while the FY2025 annual figure was $20.4 million, down 42.54% from the prior year.
• Operating Leases came in at $29.8 million for Q1 2026 at Avanos Medical, up from $20.4 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $44.5 million in Q4 2022 to a low of $20.4 million in Q4 2025.
• A 5-year average of $30.3 million and a median of $29.5 million in 2023 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases tumbled 42.54% in 2025 and gained 29.0% in 2026, its largest moves.
• Avanos Medical's Operating Leases stood at $44.5 million in 2022, then sank by 36.4% to $28.3 million in 2023, then gained by 25.44% to $35.5 million in 2024, then sank by 42.54% to $20.4 million in 2025, then surged by 46.08% to $29.8 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $29.8 million, $20.4 million, and $21.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison